GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 90 filers reported holding GENERATION BIO CO in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,187 | -96.0% | 841 | -94.2% | 0.00% | – |
| Q2 2023 | $80,295 | +2649.8% | 14,599 | +2050.1% | 0.00% | – |
| Q1 2023 | $2,920 | -66.1% | 679 | -69.1% | 0.00% | – |
| Q4 2022 | $8,626 | -33.6% | 2,195 | -12.3% | 0.00% | – |
| Q3 2022 | $13,000 | -60.6% | 2,502 | -50.8% | 0.00% | – |
| Q2 2022 | $33,000 | -77.4% | 5,085 | -74.5% | 0.00% | – |
| Q1 2022 | $146,000 | -81.7% | 19,921 | -82.3% | 0.00% | – |
| Q4 2021 | $798,000 | -50.1% | 112,684 | +76.5% | 0.00% | -100.0% |
| Q3 2021 | $1,600,000 | -62.5% | 63,826 | -59.8% | 0.00% | -66.7% |
| Q2 2021 | $4,272,000 | +24.7% | 158,792 | +31.9% | 0.00% | +50.0% |
| Q1 2021 | $3,425,000 | +2958.0% | 120,349 | +2943.7% | 0.00% | – |
| Q4 2020 | $112,000 | +522.2% | 3,954 | +571.3% | 0.00% | – |
| Q3 2020 | $18,000 | – | 589 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $58,614,000 | 5.38% |
| Yiheng Capital Management, L.P. | 1,975,146 | $13,984,000 | 0.71% |
| Artal Group S.A. | 2,814,191 | $19,924,000 | 0.54% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,613,000 | 0.34% |
| Bellevue Group AG | 3,872,180 | $27,416,000 | 0.28% |
| Casdin Capital, LLC | 1,324,275 | $9,376,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 | $24,780,000 | 0.12% |
| BVF INC/IL | 189,050 | $1,338,000 | 0.05% |
| PDT Partners, LLC | 36,843 | $261,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 17,739 | $126,000 | 0.02% |